DANISH JAMIL

Dr. DANISH JAMIL

Software, Sir Syed University of Engineering and Technology, Karachi, Sindh, Pakistan
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
DANISH JAMILDANISH JAMIL
DANISH JAMIL
Alvaro RochaAlvaro Rocha
Alvaro Rocha
Carlos FerrasCarlos Ferras
Carlos Ferras
Lung cancer remains the leading cause of cancer-related mortality worldwide, with early detection being critical for improving survival rates. While artificial intelligence (AI) has shown promise in enhancing lung cancer diagnosis and prognosis, challenges such as model generalizability, dataset diversity, and clinical validation hinder its widespread adoption. In recent years, hybrid approaches integrating deep learning with radiomics have gained attention for their potential to improve accuracy, interpretability, and robustness in lung cancer prediction. This systematic review and meta-analysis examine studies published between 2015 and 2023, focusing on hybrid AI-radiomics models that combine handcrafted radiomic features with deep learning architectures such as CNN, U-Net, and VGG-16. Additionally, machine learning classifiers like XGBoost, Random Forest, and SVM are explored in the context of radiomic feature analysis. Beyond performance evaluation, this study investigates dataset diversity, clinical validation challenges, and regulatory concerns affecting the translation of hybrid models into clinical practice. To provide a quantitative synthesis of current evidence, we conduct a meta-analysis of existing studies, assessing the effectiveness and reliability of hybrid AI-radiomics approaches compared to standalone AI models. Furthermore, an independent benchmarking experiment on the LIDC-IDRI dataset is performed to empirically validate the findings, demonstrating the superior performance of hybrid models in lung cancer diagnosis. Unlike previous reviews, this study fills a critical gap by combining both a systematic review and meta-analysis, offering a comprehensive evaluation of hybrid AI-radiomics models. The meta-analysis provides quantitative validation of these models' effectiveness, ensuring a more rigorous assessment of their real-world applicability. By identifying key limitations and opportunities, this review aims to bridge the gap between research and clinical implementation, offering insights for the development of more explainable, generalizable, and ethically responsible AI-driven solutions for lung cancer diagnosis.

1 January 2022 in International Journal of Online and Biomedical Engineering (iJOE)
Verified
Journal Article
Open access
PDF file
DANISH JAMILDANISH JAMIL
DANISH JAMIL
SPSellappan Palaniappan
Sellappan Palaniappan
SZSyed Saood Zia
Syed Saood Zia
ALAsiah Lokman
Asiah Lokman
MNMuhammad Naseem
Muhammad Naseem
Data Sources: Articles for this paper were sourced from Pub-Med and Google Scholar databases. Data Extraction: Human studies published in English from 2015 to 2021 were included. Two reviewers initially assessed abstracts of 958 papers and 192 papers were selected for future assessments. After a full review, 38 articles were selected. Results: Dietary salt is a high-risk factor for Gastric Cancer (GC) while red meat and a high-fat diet increase the risk. Alcohol intake is only a risk if consumed heavily. Conclusion: Dairy foods, vitamin C, smoked food, rich food, and Helicobacter pylori are included in the etiology of GC. So are fresh fruits, vegetables, and specific refined grains. Salt, fats, spicy foods, alcohol, red meat, and pepper increase the risk. Knowing cancer patients' nutrition problems would help intervention measures be taken to remedy the situation.

1 January 2023 in Journal of Advances in Information Technology
Verified
Journal Article
Open access
DANISH JAMILDANISH JAMIL
DANISH JAMIL
SPSellappan Palaniappan
Sellappan Palaniappan
MNMuhammad Naseem
Muhammad Naseem
ALAsiah Lokman
Asiah Lokman

29 January 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
DANISH JAMILDANISH JAMIL
DANISH JAMIL
Alvaro RochaAlvaro Rocha
Alvaro Rocha
Carlos FerrasCarlos Ferras
Carlos Ferras
Background and Objective: Lung cancer continues to be a major global health issue, with a pressing need for improved diagnostic and prognostic methods to enhance early detection and patient outcomes. The objective of this survey is to review and evaluate the current methods and models used in lung cancer diagnosis and prognosis, focusing on their strengths, limitations, and potential for future advancements. Methods: A systematic review of the literature was conducted across key databases, focusing on studies that utilize deep learning architectures, such as CNN, GoogleNet, VGG-16, U-Net, and machine learning algorithms, including XGBoost, SVM, KNN, ANN, and Random Forest. The review synthesized findings from these studies to assess the effectiveness and limitations of these computational models in the context of lung cancer detection. Results: The review identified several strengths in current models, including high accuracy in controlled environments and potential for early detection. However, significant limitations were also highlighted, such as issues with model interpretability, a lack of real-world validation, and challenges in integrating diverse diagnostic techniques. These gaps indicate the need for further research to enhance the applicability and reliability of AI-driven models in clinical settings. Conclusions: Advanced computational methods, particularly those utilizing deep learning and machine learning, hold transformative potential for lung cancer diagnosis and prognosis. However, to fully realize this potential, future research must address current challenges, such as improving model interpretability and ensuring robust validation in real-world scenarios. By overcoming these obstacles, AI-driven approaches can significantly improve patient care and outcomes in lung cancer treatment.